UB Paderborn / Katalog / Suche / in CDI

Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.189-196

2018

Link zum Volltext

Verfügbarkeit prüfen

A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI

Breast cancer research and treatment, 2014-07, Vol.146 (1), p.109-116

2014

Link zum Volltext

Verfügbarkeit prüfen

Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients

European journal of cancer (1990), 2016-03, Vol.56, p.31-36

2016

Link zum Volltext

Verfügbarkeit prüfen

Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer

Annals of oncology, 2015-02, Vol.26 (2), p.437-438

2015

Link zum Volltext

Verfügbarkeit prüfen

483 (PB-116) - The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up

European journal of cancer (1990), 2018-04, Vol.92, p.S141-S141

2018

Link zum Volltext

Verfügbarkeit prüfen

The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up

European journal of cancer (1990), 2018-04, Vol.92, p.S141

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-08-31: Withdrawal of exogenous hormones affects prognostic multigene signature results in early luminal breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P5-P5-08-31

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-09-12: Breast cancer characteristics and the levonorgestrel intrauterine device. A monocentric retrospective study

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-09-12

2016

Link zum Volltext

Verfügbarkeit prüfen

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients: an international multicentre hospital-based retrospective cohort study

Annals of oncology, 2016-10, Vol.27, p.vi49-vi49

2016

Link zum Volltext

Verfügbarkeit prüfen

An international multicentre hospital-based retrospective cohort study evaluating the prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients

Annals of oncology, 2016-09, Vol.27, p.iv60

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-13-09: Sensitive liquid chromatography-tandem mass spectrometry method for serum estradiol and estrone assessment without derivatisation, overcoming cross reactivity with exemestane

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-13-09

2013

Link zum Volltext

Verfügbarkeit prüfen

Prospective assessment of loss of grip strength by baseline BMI in breast cancer patients receiving adjuvant aromatase inhibitors or tamoxifen

European journal of cancer (1990), 2014-03, Vol.50, p.S99-S99

2014

Link zum Volltext

Verfügbarkeit prüfen

A Negative Progesterone Receptor in Luminal Her-2 Negative Breast Cancer by Age at Diagnosis: 10 Years Follow-Up

Annals of oncology, 2014-05, Vol.25, p.i8-i8

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-13-08: Arthralgia and changes in serum levels of IGF-I, its binding protein and estrogen in breast cancer patients on endocrine agents

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-13-08

2013

Link zum Volltext

Verfügbarkeit prüfen

Influence of body mass Index on breast cancer features

European journal of cancer (1990), 2014-03, Vol.50, p.S204-S204

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT3-2-04: Prospective multicenter study evaluating the effect of impaired tamoxifen metabolization on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting - The CYPTAM-BRUT 2 trial

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.OT3-2-04-OT3-2-04

2013

Link zum Volltext

Verfügbarkeit prüfen

P270 Outcome of HER2 positive breast cancer by PR expression since the introduction of trastuzumab

Breast (Edinburgh), 2015-03, Vol.24, p.S119-S119

2015

Link zum Volltext

Verfügbarkeit prüfen

29PA NEGATIVE PROGESTERONE RECEPTOR IN LUMINAL HER-2 NEGATIVE BREAST CANCER BY AGE AT DIAGNOSIS: 10 YEARS FOLLOW-UP

Annals of oncology, 2014-05, Vol.25 (suppl_1), p.i10-i10

2014

Link zum Volltext

Verfügbarkeit prüfen

Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer

Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Vol.26 (2), p.437-438

2015

Link zum Volltext

Verfügbarkeit prüfen

Independence within reach. Ergotherapy treatment of children with a congenital reduction defect

Tijdschrift voor kindergeneeskunde, 1992-08, Vol.60 (4), p.115-119

1992

Link zum Volltext

Verfügbarkeit prüfen

Drivers of household food availability in sub-Saharan Africa based on big data from small farms

Proceedings of the National Academy of Sciences - PNAS, 2016-01, Vol.113 (2), p.458-463

2016

Link zum Volltext

Verfügbarkeit prüfen

The microbiome of diabetic foot osteomyelitis

European journal of clinical microbiology & infectious diseases, 2016-02, Vol.35 (2), p.293-298

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluating coffee yield gaps and important biotic, abiotic, and management factors limiting coffee production in Uganda

European journal of agronomy, 2015-02, Vol.63, p.1-11

2015

Link zum Volltext

Verfügbarkeit prüfen

Closing the cassava yield gap: An analysis from smallholder farms in East Africa

Field crops research, 2009-04, Vol.112 (1), p.24-36

2009

Link zum Volltext

Verfügbarkeit prüfen

Increasing land pressure in East Africa: The changing role of cassava and consequences for sustainability of farming systems

Agriculture, ecosystems & environment, 2008-12, Vol.128 (4), p.239-250

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study

A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI

Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients

Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer

483 (PB-116) - The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up

The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up

Abstract P5-08-31: Withdrawal of exogenous hormones affects prognostic multigene signature results in early luminal breast cancer

Abstract P6-09-12: Breast cancer characteristics and the levonorgestrel intrauterine device. A monocentric retrospective study

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients: an international multicentre hospital-based retrospective cohort study

An international multicentre hospital-based retrospective cohort study evaluating the prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients

Abstract P1-13-09: Sensitive liquid chromatography-tandem mass spectrometry method for serum estradiol and estrone assessment without derivatisation, overcoming cross reactivity with exemestane

Prospective assessment of loss of grip strength by baseline BMI in breast cancer patients receiving adjuvant aromatase inhibitors or tamoxifen

A Negative Progesterone Receptor in Luminal Her-2 Negative Breast Cancer by Age at Diagnosis: 10 Years Follow-Up

Abstract P1-13-08: Arthralgia and changes in serum levels of IGF-I, its binding protein and estrogen in breast cancer patients on endocrine agents

Influence of body mass Index on breast cancer features

Abstract OT3-2-04: Prospective multicenter study evaluating the effect of impaired tamoxifen metabolization on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting - The CYPTAM-BRUT 2 trial

P270 Outcome of HER2 positive breast cancer by PR expression since the introduction of trastuzumab

29PA NEGATIVE PROGESTERONE RECEPTOR IN LUMINAL HER-2 NEGATIVE BREAST CANCER BY AGE AT DIAGNOSIS: 10 YEARS FOLLOW-UP

Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer

Independence within reach. Ergotherapy treatment of children with a congenital reduction defect

Drivers of household food availability in sub-Saharan Africa based on big data from small farms

The microbiome of diabetic foot osteomyelitis

Evaluating coffee yield gaps and important biotic, abiotic, and management factors limiting coffee production in Uganda

Closing the cassava yield gap: An analysis from smallholder farms in East Africa

Increasing land pressure in East Africa: The changing role of cassava and consequences for sustainability of farming systems

Suchergebnisse filtern